alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32



CERTIFICATION PURSUANT TO

18 U.S.C.
SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report on Form 10-Q of Aurora Foods Inc. (the Company) for the quarterly period ended September 30, 2003, as filed with the Securities and Exchange Commission on the date hereof (the
Report), Dale F. Morrison, as Chief Executive Officer of the Company, and William R. McManaman, as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to § 906 of the
Sarbanes-Oxley Act of 2002, that:



(1) The Report fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                                                                                            
|--------------------------------------------------------------------------------------------
|/s/    Dale F. Morrison                                                                     
|                                                                                            
|Dale F. Morrison Chairman of the Board and Interim Chief Executive Officer November 14, 2003
|                                                                                            
|/s/    William R. McManaman                                                                 
|                                                                                            
|William R. McManaman Executive Vice
President and Chief Financial Officer November 14,
2003 



This certification accompanies each
Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of § 18 of the Securities Exchange Act of 1934, as
amended.



A signed original of this written statement required by Section 906
has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.



---
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

September 17, 2019

RE: Product Exclusion Request Number USTR-2018-0025-10476

Palo Alto Networks, Inc: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/%2434_Billion_Exclusions_Gr

anted_September.pdf. 

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Joseph Barloon

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

January 23, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-3100

NSK Corporation:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that this particular product is available 

only from China.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
II 

117TH CONGRESS 

2D SESSION S. 3516 

To require the Secretary of Health and Human Services to provide emergency 

use authorization with respect to certain COVID–19 diagnostic tests 

approved for use in the European Union. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 18, 2022 

Mr. SASSE introduced the following bill; which was read twice and referred 

to the Committee on Health, Education, Labor, and Pensions 

A BILL 

To require the Secretary of Health and Human Services 

to provide emergency use authorization with respect to 

certain COVID–19 diagnostic tests approved for use in 

the European Union. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Increase Access to 

5 COVID Testing Act’’. 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•S 3516 IS

1 SEC. 2. EMERGENCY USE APPROVAL OF CERTAIN COVID–19 

2 TESTS. 

3 (a) IN GENERAL.—For the duration of the public 

4 health emergency declared under section 319 of the Public 

5 Health Service Act (42 U.S.C. 247d) with respect to 

6 COVID–19, the Secretary of Health and Human Services 

7 shall authorize the introduction into interstate commerce, 

8 pursuant to section 564 of the Federal Food, Drug, and 

9 Cosmetic Act (21 U.S.C. 360bbb–3), without regard for 

10 any specific criteria under subsection (c)(2) of such sec11 tion, of any antigen diagnostic test to detect SARS–CoV– 

12 2 that is described in subsection (b), upon request by the 

13 manufacturer under such section 564. 

14 (b) TESTS DESCRIBED.—An antigen diagnostic test 

15 to detect SARS–CoV–2 described in this subsection is 

16 such a test— 

17 (1) that is included on the common list of 

18 COVID–19 rapid antigen tests of the European 

19 Commission Directorate-General for Health and 

20 Food Safety; and 

21 (2) for which the emergency use authorization 

22 request is for an at-home, or other non-laboratory 

23 site, use, without a prescription. 

24 (c) TERMS OF AUTHORIZATION.— 

25 (1) IN GENERAL.—A diagnostic test authorized 

26 as described in subsection (a) shall be subject to the 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•S 3516 IS

1 same terms and requirements as other products au2 thorized under section 564 of the Federal Food, 

3 Drug, and Cosmetic Act (21 U.S.C. 360bbb–3). 

4 (2) CHANGE IN STATUS IN THE EU.—In the 

5 case of an antigen diagnostic test authorized as de6 scribed in subsection (a), if the European Commis7 sion Directorate-General for Health and Food Safety 

8 removes such test from the common list described in 

9 subsection (b)(1), the Secretary of Health and 

10 Human Services, not later than 30 days after such 

11 removal from the common list, shall conduct a re12 view of the test to determine whether the emergency 

13 use authorization under section 564 of the Federal 

14 Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb– 

15 3) should continue. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

November 19, 2018

RE: Product Exclusion Request Number: USTR-2018-0025-2031

Reelcraft Industries:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn
IN THE SUPREME COURT OF THE STATE OF MONTANA

No. DA 22-0240

STATE OF MONTANA,

Plaintiff and Appellee,

v.

JASON RALPH EBY,

Defendant and Appellant.

ORDER

Upon consideration of Appellant’s motion for extension of time, 

and good cause appearing,

IT IS HEREBY ORDERED that Appellant is granted an extension 

of time to and including June 23, 2023, within which to prepare, file, 

and serve Appellant’s opening brief on appeal.

Electronically signed by:

Beth Baker

Justice, Montana Supreme Court

May 16 2023

05/16/2023

Case Number: DA 22-0240
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

February 7, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-1921

Northern Tool & Equipment:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests. 

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
<PAGE>   1
                                                                    Exhibit 23.1




                         INDEPENDENT AUDITORS' CONSENT



The Board of Directors
Lincare Holdings Inc.:


We consent to incorporation by reference in the Registration Statements Nos.
33-55202, 33-595656, 33-90602 and 333-46969 on Form S-8 of Lincare Holdings
Inc. of our report dated January 28, 1998, relating to the consolidated balance
sheets of Lincare Holdings Inc. and subsidiaries as of December 31, 1997 and
1996, and the related consolidated statements of operations, stockholders'
equity, and cash flows and related consolidated financial statement schedule
for each of the years in the three-year period ended December 31, 1997, which
report appears in the December 31, 1997 annual report on Form 10-K of Lincare
Holdings Inc.




                                        KPMG PEAT MARWICK LLP




St. Petersburg, Florida
March 24, 1998
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

September 17, 2019

RE: Product Exclusion Request Number USTR-2018-0025-1667

Titan Flow Control: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/%2434_Billion_Exclusions_Gr

anted_September.pdf. 

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Joseph Barloon

General Counsel
EXHIBIT 32.2



CFO CERTIFICATION PURSUANT TO



SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



(18 U.S.C. SECTION 1350)



In connection with Form 10-Q of POZEN Inc. (the Company) , as filed with the Securities and Exchange Commission (the Report), I,
William L. Hodges, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



| | 1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | -- | ---------------------------------------------------------------------------------------------------------------------------------



| | 2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                       |  |                        
|---------------------- |  | -----------------------
|Date: November 9, 2005 |  | /s/ William L. Hodges  
|                       |  | William L. Hodges      
|                       |  | Chief Financial Officer



A signed original of this written
statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been
provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.



37
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from balance
sheets and statements of operations and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   9-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998             DEC-27-1997
<PERIOD-START>                             DEC-28-1997             JAN-01-1997
<PERIOD-END>                               SEP-30-1998             SEP-27-1997
<CASH>                                           1,919                   4,341
<SECURITIES>                                         0                       0
<RECEIVABLES>                                   85,995                  12,180
<ALLOWANCES>                                       940                      89
<INVENTORY>                                     83,389                   4,442
<CURRENT-ASSETS>                               216,579                  30,013
<PP&E>                                         145,539                  15,468
<DEPRECIATION>                                   8,086                     640
<TOTAL-ASSETS>                               1,454,973                 374,709
<CURRENT-LIABILITIES>                          189,211                  68,463
<BONDS>                                        743,037                 239,210
<PREFERRED-MANDATORY>                                0                  61,640
<PREFERRED>                                          0                       0
<COMMON>                                           670                     291
<OTHER-SE>                                     574,886                   2,268
<TOTAL-LIABILITY-AND-EQUITY>                 1,454,973                 374,709
<SALES>                                        507,966                  92,016
<TOTAL-REVENUES>                               507,966                  92,016
<CGS>                                          209,451                  29,500
<TOTAL-COSTS>                                  209,451                  29,500
<OTHER-EXPENSES>                               209,881                  35,374
<LOSS-PROVISION>                                   940                      89
<INTEREST-EXPENSE>                              51,197                  11,800
<INCOME-PRETAX>                               (64,625)                   3,780
<INCOME-TAX>                                     (230)                   1,512
<INCOME-CONTINUING>                           (64,395)                   2,268
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                (9,325)                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                  (73,720)                   2,268
<EPS-BASIC>                                     (1.50)                    0.08
<EPS-DILUTED>                                   (1.50)                    0.08


</TABLE>
SCWC-11-0000695

IN THE SUPREME COURT OF THE STATE OF HAWAI#I

STATE OF HAWAI#I, Respondent/Plaintiff-Appellee,

vs.

RICARDO APOLLONIO, Petitioner/Defendant-Appellant.

CERTIORARI TO THE INTERMEDIATE COURT OF APPEALS

(CAAP-11-0000695; CASE NO. 1DTC-10-010161)

ORDER ACCEPTING APPLICATION FOR WRIT OF CERTIORARI

(By: Recktenwald, C.J., Nakayama, Acoba, 

McKenna, and Pollack, JJ.)

The Application for Writ of Certiorari filed on October

22, 2012 by Petitioner/Defendant-Appellant Ricardo Apollonio is

hereby accepted and will be scheduled for oral argument. The

parties will be notified by the appellate clerk regarding

scheduling.

DATED: Honolulu, Hawai#i, December 6, 2012.

James S. Tabe, /s/ Mark E. Recktenwald

for petitioner 

 /s/ Paula A. Nakayama

Brandon H. Ito, 

for respondent /s/ Simeon R. Acoba, Jr.

 /s/ Sabrina S. McKenna

 /s/ Richard W. Pollack

Electronically Filed

Supreme Court

SCWC-11-0000695

06-DEC-2012

12:44 PM
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Trade Commission

# FOR FURTHER INFORMATION CONTACT:

Theresa Kingsberry, Program Support Specialist, Federal Trade Commission, Premerger Notification Office Bureau of Competition, Room CC-5301, Washington, DC 20024 (202) 326-3100.

      ( print page 7798)    
By direction of the Commission.

Donald S. Clark,

Secretary.

[FR Doc. 2016-03035 Filed 2-12-16; 8:45 am]

 BILLING CODE 6750-01-P
### Proposed Provision: C2.8. Starting in 2026, convert all disabled-worker beneficiaries to retired-worker status upon attainment of their earliest eligibility age (EEA) rather than their normal retirement age (NRA). After conversion, apply the early retirement reduction for retirement at EEA (currently 30 percent for those age 62 in 2026) phased in over 40 years.